---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-022005"
form_type: "8-K"
ticker: "INBS"
cik: "0001725430"
company_name: "INTELLIGENT BIO SOLUTIONS INC."
filed_at: "2025-11-12T23:59:59+00:00"
generated_at: "2026-05-16T21:20:12.542477+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Intelligent Bio Solutions reports record Q1 revenue of $1.11M, up 28% YoY; gross margin expands to 46.6%

## Summary
- Revenue $1.11M (+28% YoY, +32% sequential); cartridge sales 57.6% of total revenue.
- Gross margin 46.6%, up 690 bps YoY, citing operational efficiency and product mix.
- Added 33 new customer accounts; total active accounts 492 across 24+ countries.
- Secured major contract with London public transport operator covering 14 sites and 4,400+ staff.
- Expanded portfolio with SmarTest® Patch and global distribution deal with SMARTOX®.

## SEC filing metadata
- accession: 0001493152-25-022005
- form_type: 8-K
- ticker: INBS
- cik: 0001725430
- company_name: INTELLIGENT BIO SOLUTIONS INC.
- filed_at: 2025-11-12T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1725430/000149315225022005/0001493152-25-022005-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1725430/000149315225022005/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-022005
- JSON: https://secwatch.observer/filing/0001493152-25-022005.json
- Plain text: https://secwatch.observer/filing/0001493152-25-022005.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.